Claritev has delivered outstanding financial results for the second quarter of 2026, maintaining a trajectory of consistent top-line expansion. The company reported revenue of $257.5 million, reflecting a 6.6% year-over-year increase, marking its fifth consecutive quarter of growth. This period also saw a notable improvement in its net loss, which stood at $59.2 million, a reduction from $62.6 million in the prior year. Adjusted EBITDA reached $155.8 million, showing a 1.1% year-over-year rise and representing the highest performance in thirteen quarters, despite a slight decrease in the Adjusted EBITDA Margin to 60.5% due to investments in transformative initiatives. The company's booking momentum was particularly strong, with H1 2026 bookings hitting $74 million in Annual Contract Value (ACV), a 150% surge compared to the first half of 2025. Q2 2026 bookings alone contributed $30 million in ACV, surpassing the total bookings for the entire 2025 fiscal year. Claritev also revised its full-year revenue guidance upwards to $1 billion to $1.02 billion, and its Adjusted EBITDA guidance to $610 million to $620 million, demonstrating confidence in its continued growth and operational efficiency.
A pivotal aspect of Claritev's success lies in its strategic market expansion and technological innovation, particularly with artificial intelligence. The company is actively pursuing a vertical market expansion, focusing on Third-Party Administrators (TPAs) and the Medicare Advantage market to diversify its revenue streams. This strategy has already yielded significant results, with TPA bookings contributing substantially to the second quarter's new business. Technology modernization is a core pillar, with AI playing a crucial role in automating claims validation and enhancing developer productivity. More than half of Claritev's code is now AI-generated, and AI-powered tools are improving efficiency, accelerating decision-making, and delivering superior outcomes for clients. The company's independent dispute resolution (IDR) outcomes consistently outperform industry averages by approximately 8 percentage points, further solidifying its competitive edge. Moreover, AI-driven solutions like the ProPricer product have generated over $1 billion in cumulative healthcare savings for clients, showcasing the tangible benefits of its advanced technological integration.
Despite these achievements, Claritev acknowledges and addresses certain market challenges and risks. Medical inflation, currently between 8% and 10% annually, continues to exert pressure on the healthcare system, while the No Surprises Act (NSA) system faces overwhelming volume, leading to administrative burdens. However, Claritev views these challenges as opportunities to leverage its expertise in affordability and transparency. The company's solutions for managing NSA claims at scale and its advanced payment and revenue integrity portfolio are critical in helping clients navigate regulatory complexities and reduce costs. Claritev's management team emphasizes that the current growth is sustainable and part of a multi-year transformation strategy aimed at enhancing operating leverage, reducing debt, and unlocking free cash flow to maximize long-term value for stakeholders. The company's commitment to innovation and strategic market engagement positions it for sustained leadership in the healthcare technology sector.
Claritev's impressive performance in the second quarter of 2026 reflects a dynamic and forward-thinking company successfully navigating a complex healthcare landscape. By strategically expanding into new markets, aggressively integrating AI, and continuously improving its core offerings, Claritev is not only achieving financial milestones but also contributing significantly to making healthcare more affordable and transparent for consumers. This dedication to innovation and operational excellence sets a high standard, promising a future where technological advancements drive tangible benefits and foster a more efficient, equitable healthcare system for everyone.
